Skip to content
COA & Batch Documentation Available Explore Research Peptides
Research Grade Independently Tested

SS-31

Verified Synthesis Batch COA Available
≥ 99% (HPLC) CAS 736992-21-5 C₃₂H₄₉N₉O₅
$89.99 AUD · GST incl.
  • Certificate of Analysis available for every batch
  • Form: Lyophilised Powder
  • Storage: 2°C-8°C (Refrigerated)
  • Australia-wide, discreet tracked dispatch
  • Research Use Only - not for human or veterinary use

SS-31 is a mitochondria-targeted compound used in laboratory and clinical studies associated with the study of mitochondrial functioning, cellular energy production and oxidative stress. Also referred to as elamipretide and MTP-131, SS-31 has received scientific attention owing to its association with cardiolipin, a significant phospholipid found within the inner mitochondrial membrane.

SS-31 10mg research grade specifies the amount that can be used for controlled laboratory studies. Scientists interested in mitochondrial biology want to study the effects of SS-31 on mitochondrial membranes, electron transport, ATP generation and reactive oxygen species in experimental settings.

Scientific interest in SS-31 peptide research continues to increase worldwide, including in Australia where scientists study mitochondrial dysfunctions and cellular bioenergetics. Nevertheless, one should exercise care in interpreting results of scientific research as conclusions drawn from cell, animal and clinical studies are not necessarily applicable to other experimental models.

What Is SS-31?

SS-31 is an artificial tetrapeptide because it comprises four amino acid residues. It has also become popular by the name of SS-31, elamipretide or MTP-131.

SS-31 differs from many other antioxidant compounds because it has been studied due to its capacity to be targeted to the inner mitochondrial membrane. Researchers have noted that the interaction between SS-31 and cardiolipin will give clues about the organisation and bioenergetics of the mitochondria membrane.

The mitochondria play an important role in the production of cellular energy required for life. Disruption in the functioning of the mitochondria means that the ATP synthesis, oxidative state, electron transport and cellular signalling will also change.

Why Is SS-31 Being Studied?

SS-31 is under investigation as mitochondrial dysfunction is linked to many biological and medical issues. Various scientific experiments have been performed for elamipretide in terms of its relevance to skeletal muscle, cardiovascular system, renal function, neurology, and mitochondrial diseases.

Key topics of SS-31 peptide research are:

  • mitochondrial membrane integrity and cardiolipin;
  • cellular metabolism and production of ATP;
  • oxidative stress and reactive oxygen species;
  • electron transport chain;
  • mitochondrial cristae morphology;
  • study of muscles and exercise physiology;
  • cardiovascular and renal experiments;
  • age-related mitochondrial alterations.

This list of research topics does not prove that SS-31 is a universal therapy or health product. The importance of results from experiments depends on the experiment itself, type of experimental model used, dosage and duration of the experiment and parameters measured.

How Does SS-31 Work?

SS-31 operates through a mitochondrial/cardiolipin pathway.

Cardiolipin is a specific phospholipid found mainly in the inner mitochondrial membrane. It helps to form the structure of the membrane and to perform proteins responsible for oxidative phosphorylation.

Scientists have observed SS-31 interactions with cardiolipin and effects on mitochondrial membrane organization. This interaction was researched in respect to cristae formation, functioning of the respiratory chain, oxidative stress and ATP synthesis.

In other words, it is being studied how SS-31 can help mitochondria to operate more efficiently in certain experimental circumstances. According to scientific literature, SS-31 was linked to the stability of mitochondrial membranes, to lower oxidative stress and better energy generation in some experiments.

A reaction to this molecule may differ greatly depending on the organism used.

Understanding SS-31 Dosage

SS-31 Dosage may mean different things in different settings. “A 10mg vial” is the total volume of the study material contained in the vial; however, it does not establish a standardized dosage or the protocol.

The following elements can influence the concentration and exposure of substances used in scientific studies, including:

  • The nature of the experiment and its objectives;
  • In vitro or in vivo experiment techniques;
  • Biological or other models;
  • The route and schedule of the exposure in the experiment;
  • The duration of the experiment itself;
  • Scientific procedure.

Experimental concentrations should be calculated using the appropriate methodologies and standards and should not be suggested as a personal dosage.

SS-31 and Research Quality

Quality of research is very critical particularly where specialised peptides are involved. The purity percentage alone does not tell the whole story regarding material quality.

Scientists assessing SS-31 peptide need to take into account identity testing, purity assessment, traceability of batches, documentation and proper storage. Techniques for purity and identity testing include high-performance liquid chromatography and mass spectrometry.

High quality research materials must also be traceable and well documented, being associated with particular material. Good handling is critical since different storage conditions, light, temperature changes and freeze-thaw cycles may affect the stability of the peptide.

SS-31 in Australia

Searches for SS-31 Australia may indicate increasing interest in mitochondrial peptides and biochemistry studies. Laboratories and scientists in Australia looking into SS-31 should differentiate between research substances and therapeutic supplies of SS-31 that are approved.

The regulation status, import rules, and permissible applications may be modified from time to time. Scientists and organizations in Australia should verify any applicable rules before acquisition, importation, supply and application of research peptides.

Australian scientists researching SS-31 peptide suppliers could pay more attention to documents, batch identification, analysis details, shipment details, and specifications of a peptide rather than marketing statements.

What to Consider Before You Buy SS-31

For researchers looking to purchase SS-31 in Australia, there are issues of product quality and documentation that must be considered. Price will give you little indication of whether the product is a genuine peptide.

Before deciding to purchase SS-31 10mg for use in laboratory-based research, think about how well the supplier handles issues relating to analytical testing, batch tracking, labelling, storage and research information.

A legitimate research material is one that can be clearly identified and documented. Researchers must also look at whether the analytical reports available correlate with the batch being sold.

Do not take any statements at face value that may imply guaranteed anti-ageing, performance, energy or disease treatment. Research into SS-31 is highly specialized and scientific and should be evaluated accordingly.

Safety and Current Research

The progress of SS-31 has been made past the level of laboratory studies and has reached the level of human clinical trials. Studies on the use of elamipretide have been conducted in the context of mitochondria as well as other diseases, but lab studies are continuing on how it impacts cardiolipin, oxidative phosphorylation, mitochondria, and energy metabolism.

It must be noted that clinical trials do not mean that all products of SS-31 available on the web are suitable for private use because the research grade products and medicines belong to different categories and are not equivalent.

Current findings must be analyzed based on research participants, outcomes, time frame and methodology of research.

Frequently Asked Questions

SS-31 is a synthetic mitochondria-targeting tetrapeptide also known as elamipretide or MTP-131. It is studied for its interaction with cardiolipin and mitochondrial bioenergetics.

SS-31 10mg describes a research format containing a total of 10 milligrams of peptide material. It does not represent a universal experimental dosage.

Yes. SS-31 and elamipretide are names used for the same peptide compound in scientific and clinical literature.

SS-31 is described as a mitochondrial peptide because research focuses on its interaction with components of the inner mitochondrial membrane, particularly cardiolipin.

Cardiolipin is a specialised phospholipid found mainly in the inner mitochondrial membrane. It plays an important role in mitochondrial structure and energy-producing processes.

Research has examined whether SS-31 can improve mitochondrial efficiency and ATP production under particular experimental conditions. Results depend on the model and should not be interpreted as guaranteed effects.

Research areas include mitochondrial dysfunction, oxidative stress, cellular energy metabolism, muscle physiology, cardiovascular biology, kidney research and mitochondrial disorders.

Availability depends on the supplier and applicable regulatory or import requirements. Researchers should verify current Australian requirements and assess product documentation before ordering.

Storage should follow the specific instructions provided with the product and its documentation. Temperature control, protection from light and careful handling may be important for peptide stability.

Researchers should assess identity and purity testing, batch traceability, analytical documentation, labelling, storage guidance and supplier transparency before selecting SS-31 peptide for laboratory use.

Notice

SS-31 is an investigational peptide intended for scientific research purposes. It should not be presented as an approved therapeutic medicine in Australia. Researchers and organisations should verify the current regulatory requirements applicable to their intended research, importation, possession and supply activities.

Disclaimer

This content is provided for educational, scientific and research-information purposes only. It does not provide medical advice, treatment recommendations or personal dosage instructions. Available evidence concerning SS-31 includes preclinical research and ongoing or completed clinical investigations. Further research is required to better understand its safety, pharmacology and potential efficacy for specific research applications.

References

5 sources
  1. Szeto HH.
    First-in-Class Cardiolipin-Protective Compound as a Therapeutic Agent to Restore Mitochondrial Bioenergetics.
    British Journal of Pharmacology. 2014;171(8):2029-2050.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/24117165/
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC3976620/
  2. Birk AV, Chao WM, Bracken C, Warren JD, Szeto HH.
    Targeting Mitochondrial Cardiolipin and the Cytochrome c/Cardiolipin Complex to Promote Electron Transport and Optimize Mitochondrial ATP Synthesis.
    British Journal of Pharmacology. 2014;171(8):2017-2028.
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC3976619/
  3. Birk AV, Liu S, Soong Y, et al.
    The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin.
    Journal of the American Society of Nephrology. 2013;24(8):1250-1261.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/23813215/
  4. Karaa A, Haas R, Goldstein A, Vockley J, Weaver WD, Cohen BH.
    Randomized Dose-Escalation Trial of Elamipretide in Adults with Primary Mitochondrial Myopathy.
    Neurology. 2018;90(14):e1212-e1221.
    PubMed: https://pubmed.ncbi.nlm.nih.gov/29500292/
    Full Text: https://pmc.ncbi.nlm.nih.gov/articles/PMC5890606/
  5. Australian Government, Department of Health, Disability and Ageing.
    Concerns Regarding the Public Health Risks Associated with Unapproved Peptide Products.
    Australian Government. 19 June 2026.
    Australian Government: https://www.health.gov.au/news/concerns-regarding-the-public-health-risks-associated-with-unapproved-peptide-products?language=en
Medically & Scientifically Reviewed By

Dr. Priyanka Goel

Scientific & Medical Content Reviewer

Information last reviewed: 9 Jul 2026

The products and information offered by Verified Peptides are intended for legitimate laboratory, analytical and scientific research applications only. Products are not for human or veterinary use, and are not therapeutic goods. The results of studies should be interpreted based on the experimental model and the limitations of the existing evidence base.

Product information and educational materials are provided only for research and informational purposes and must not be interpreted as medical advice, diagnosis or treatment.

Added to cart
View Cart Checkout